U.S. markets close in 1 hour 41 minutes
  • S&P 500

    4,576.95
    +9.95 (+0.22%)
     
  • Dow 30

    34,473.77
    -9.95 (-0.03%)
     
  • Nasdaq

    15,485.22
    -52.47 (-0.34%)
     
  • Russell 2000

    2,193.73
    -5.18 (-0.24%)
     
  • Crude Oil

    66.08
    -0.10 (-0.15%)
     
  • Gold

    1,782.90
    +6.40 (+0.36%)
     
  • Silver

    22.33
    -0.49 (-2.13%)
     
  • EUR/USD

    1.1321
    -0.0018 (-0.16%)
     
  • 10-Yr Bond

    1.4380
    -0.0050 (-0.35%)
     
  • GBP/USD

    1.3281
    -0.0020 (-0.15%)
     
  • USD/JPY

    112.7430
    -0.4370 (-0.39%)
     
  • BTC-USD

    57,082.00
    -878.45 (-1.52%)
     
  • CMC Crypto 200

    1,456.51
    -12.57 (-0.86%)
     
  • FTSE 100

    7,168.68
    +109.23 (+1.55%)
     
  • Nikkei 225

    27,935.62
    +113.86 (+0.41%)
     

Merck stock gains after profit and revenue rise above expectations, and upbeat full-year outlook

·1 min read
Merck stock gains after profit and revenue rise above expectations, and upbeat full-year outlook
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Shares of Merck & Co. Inc. rose 1.0% in premarket trading Thursday, after the drug maker and animal health company reported third-quarter profit and revenue that rose above expectations and provided and upbeat full-year outlook. Net income rose to $4.57 billion, or $1.80 a share, from $2.94 billion, or $1.16 a share, in the year-ago period. Excluding nonrecurring items, adjusted earnings per share rose to $1.75 from $1.37, and beat the FactSet consensus of $1.55. Sales grew 20.4% to $13.15 billi